Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak ...

Cytokinetics (CYTK) came out with a quarterly loss of $1.36 per share versus the Zacks Consensus Estimate of a loss of $1.41. This compares to loss of $1.33 per share a year ago. These figures are ...

U.S. enterprise demand is voracious for the company's artificial intelligence (AI)-powered software platforms.

Fabrinet proffered guidance for its current (fourth) quarter, forecasting that it will book revenue of $860 million to $900 ...

Recursion Pharmaceuticals stock falls due to weaker-than-expected first-quarter results, along with the abandonment of ...

It was a mixed second quarter for Tyson Foods, which saw net income of $380 million, and adjusted earnings of 92 cents per ...

The company reported $70.1 billion in revenue and earnings of $3.46 per share, compared to the consensus estimates of $68.4 ...

Smucker (SJM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.